Molecular Diagnostics

Tumor Biomarker Panel Improves Identification of Candidates for Lung Cancer Screening
Use of a blood-based tumor biomarker panel in combination with modeling according to results of PLCOm2012 (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) significantly improved risk assessment for lung cancer screening. More...17 Jan 2022

Meridian Receives FDA Clearance for Rapid Fluorescent Immunoassay for Detection of Campylobacter Infection
Meridian Bioscience, Inc. (Cincinnati, OH, USA) has received U.S. Food and Drug Administration (FDA) clearance for its Curian Campy assay developed to be utilized on the Curian immunofluorescent testing platform. More...14 Jan 2022

ddPCR Developed for BCR-ABL1 Fusion Transcript in B-Lymphoblastic Leukemia
Droplet digital polymerase chain reaction (ddPCR) is a novel polymerase chain reaction (PCR) technique reliant on massive sample partitioning to generate individual reaction chambers (droplets) in which individual amplification targets are detected. More...12 Jan 2022
Long Mononucleotide Repeat Markers Validated for Microsatellite Instability Detection
Mismatch repair deficiency (dMMR) predicts response to immune checkpoint inhibitor therapy in solid tumors. Long mononucleotide repeat (LMR) markers may improve the interpretation of microsatellite instability (MSI) assays. More...12 Jan 2022

Commercial RT-PCR Tests Compared to Culture for Bacterial Gastroenteritis
Nucleic acid-based testing (culture-independent diagnostic testing, CIDT) for bacterial gastroenteritis offers three major advantages over culture-based diagnosis: it has better analytical sensitivity, is less labor intensive through automation, and has faster turnaround times. More...11 Jan 2022


In Other News
Novel Protein Biomarkers Identified for Prostate Cancer Aggressiveness
Menstrual Blood Testing With Capture Sequencing Detects High-Risk Human Papillomavirus
Sex Hormone–Binding Globulin Is a Biomarker for Cardiovascular Disease Risk Independent of Total Testosterone Concentration
Parkinson’s Disease Patients Have More Inflammatory Bacteria in Their Noses
Certain Protein Ectodomains in Cerebrospinal Fluid Are Diagnostic Biomarkers for Autism
Bacterial Communities Diverge in The Lower Airways of CF Children
Intratumor Heterogeneity Analyzed in Neuroblastoma
Epigenetic Biomarkers for Early Rheumatoid Arthritis Detection
Genomic Screening Can Identify Risk for Amyloid Cardiomyopathy
Cheek Swab Test Could Identify Biomarkers for Rheumatoid Arthritis
Rapid Biopsy Approach Shortens Time Required to Diagnose HPV-linked Head and Neck Cancers
Targeted RNA-Sequencing Panel Detects Gene Fusions in Solid Tumors
A Device for Rapid and Accurate Diagnosis of Hepatitis C Infections
Biomarker Predicts Potential Benefit of Checkpoint Inhibitor Therapy for Brain Cancer Patients
Same Day Test Identifies Secondary Infections in COVID-19 Patients
A Rapid and Sensitive Lateral Flow Test for Diagnosis of Schistosomiasis
First One-Hour, Direct-from-Blood Sepsis Test Receives FDA Clearance
Liquid Biopsy Predicts Therapy Response in Patients with Late-Stage Throat Cancer
Serum MicroRNA Panel Predict P-Tau/Aβ42 in CSF in Alzheimer's Disease
Biomarkers Predict Disease Progression for Patients with Late-stage Brain Tumors
Siemens Introduces New Intelligent, Integrated IVD Solutions Virtually at EUROMEDLAB 2021
Blood and Saliva Samples Can Be Used to Detect Genetic Markers for Liver Cancer
Next-Generation Sequencing Impacts All Aspects of Myelodysplastic Syndrome Care
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.








